Allegheny Financial Group LTD purchased a new position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,698 shares of the company’s stock, valued at approximately $224,000. Several other hedge funds and other institutional investors have also […]
Brown Advisory Inc. raised its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 2.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,113,413 shares of the company’s stock after buying an additional 23,831 shares during the quarter. Brown […]
Quadrant Capital Group LLC raised its position in shares of Molina Healthcare, Inc. (NYSE:MOH – Free Report) by 6.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 886 shares of the company’s stock after buying an additional 54 shares during […]
Robeco Institutional Asset Management B.V. cut its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 29.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 109,321 shares of the company’s stock after selling 44,746 shares during […]
Massachusetts Financial Services Co. MA raised its position in shares of Banc of California, Inc. (NYSE:BANC – Free Report) by 345.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,291,541 shares of the bank’s stock after buying an additional 1,777,330 shares during […]